Fred;s response on what type C meeting with FDAA type C meeting is a meeting requested by the company to further discuss certain points. In our case, we requested this meeting to make sure the FDA was OK with our plan going forward regarding the requested additional assays and in-process control related to the plasminogen manufacturing process.
The meeting took place mid-September and we are now awaiting the final written minutes from the FDA before providing an update to our shareholders. I’m hoping to have something to report on around mid-October.
Hope this helps